These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6203376)

  • 21. Cefoperazone pharmacokinetics and sputum levels after single/multiple i.m. injections in bronchopneumopathic patients and bone, pulmonary and prostatic tissue penetration.
    Braga PC; Scaglione F; Villa S; Scarpazza G; Gagliardi V; Biella G; Manganelli V; Paiola G; Fraschini F
    Int J Clin Pharmacol Res; 1983; 3(5):349-55. PubMed ID: 6678828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies with cefoperazone in the biliary disease].
    Morinaga T; Furukawa M; Nakata T; Yamada R; Itoh S; Maeda S; Itose K; Ohtsubo M
    Jpn J Antibiot; 1985 Jan; 38(1):128-32. PubMed ID: 3989972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Panou C; Adamakis I; Giamarellou H
    J Urol; 2001 Jan; 165(1):97-9. PubMed ID: 11125373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic study on adenomatous prostate tissue concentrations of cefoperazone. Clinical efficacy and patient tolerance of intramuscular cefoperazone treatment of chronic bacterial prostatitis.
    Melloni D; Ammatuna P; Formica P; Falletta V; Gaglio F; Cacciatore M; Messina G
    Chemotherapy; 1989; 35(6):410-5. PubMed ID: 2612230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics of cefoperazone in end-stage renal failure patients on peritoneal dialysis].
    Okuda T; Katoh T; Takaichi K; Matsunaga H; Uchida S; Kurokawa K; Nihei H
    Jpn J Antibiot; 1986 Oct; 39(10):2775-9. PubMed ID: 3806960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gentamicin level in the prostate and its pharmacokinetics in patients with benign prostatic hypertrophy].
    Dyderski S; Sokołowski W
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):517-9. PubMed ID: 1705021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study of cefoperazone levels in the cerebrospinal fluid of patients with hydrocephalus].
    Asahi S; Mori N; Tajika Y; Kagawa M
    Jpn J Antibiot; 1985 Jan; 38(1):121-7. PubMed ID: 3989971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prostatic tissue levels of ceftizoxime].
    Hoshi S; Kimura M; Kuwahara M; Orikasa S; Nakano S; Chiba R; Ishii N; Kato M; Morita M; Kato H
    Hinyokika Kiyo; 1985 May; 31(5):863-70. PubMed ID: 3901702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transfer of ceftizoxime into serum and prostatic tissue].
    Fujisawa M; Mizunaga M; Arima S; Tokunaka S; Inada F; Takamura T; Yachiku S
    Hinyokika Kiyo; 1985 Oct; 31(10):1855-9. PubMed ID: 2418658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The concentration of doxycycline in human prostate gland and its role in the treatment of prostatitis.
    Oosterlinck W; Wallijn E; Wijndaele JJ
    Scand J Infect Dis Suppl; 1976; (9):85-8. PubMed ID: 63989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Concentration of antibiotics (cefoperazone) in human brain, brain tumor tissue and cerebrospinal fluid].
    Ito H; Funaki N; Kitamura Y; Shoin K; Nagatani H; Yamamoto S
    No Shinkei Geka; 1984 May; 12(6):681-6. PubMed ID: 6087180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and prostatic tissue concentrations of ofloxacin.
    Fujita K; Munakata A
    Clin Ther; 1988; 10 Spec No():32-5. PubMed ID: 3233627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on Suncefal (cefpiramide) concentration in prostatic tissue and bladder wall].
    Okishio N; Yonezu M; Hanai S; Ishiguro K; Yanaoka M; Naide Y
    Hinyokika Kiyo; 1988 Mar; 34(3):551-4. PubMed ID: 2455441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Astromicin sulfate concentration in human prostatic tissue after an intramuscular injection].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1988 Oct; 34(10):1865-8. PubMed ID: 2469325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of levels of latamoxef in prostatic tissue and bladder mucosal tissue].
    Nakata Y; Mizunaga M; Morikawa M; Osanai H; Fujisawa M; Inada F; Yachiku S
    Hinyokika Kiyo; 1987 Feb; 33(2):289-93. PubMed ID: 2438917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concentration of cefoperazone in various tissues of the urogenital system (author's transl)].
    Schalkhäuser K; Adam D
    Arzneimittelforschung; 1981; 31(10):1770-2. PubMed ID: 6459099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the diffusion of cephapirin into prostatic tissue].
    Adam D; Hofstetter AG; Staehler G
    Fortschr Med; 1977 Sep; 95(34):2107-9. PubMed ID: 71258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of cefoperazone on acute prostatitis and epididymitis].
    Hihara T; Hoshino H; Kawashima T; Nagata Y; Kawamura N
    Hinyokika Kiyo; 1986 Jun; 32(6):897-901. PubMed ID: 3766351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.